Copyright
©The Author(s) 2020.
World J Gastrointest Oncol. Mar 15, 2020; 12(3): 347-357
Published online Mar 15, 2020. doi: 10.4251/wjgo.v12.i3.347
Published online Mar 15, 2020. doi: 10.4251/wjgo.v12.i3.347
Figure 2 Overall survival for patients with stage IV duodenal adenocarcinoma and intestinal-type papilla of Vater adenocarcinoma compared based on treatment modality.
A: Overall survival of patients treated with local therapy of metastases compared with systemic therapy or supportive care (all stage IV patients were included); B: Subgroup analysis of patients with liver metastases eligible for local treatment only. Kaplan-Meier curves are shown per treatment group. LT: Local treatment of metastases; ST: Systemic therapy; SC: Supportive care; No. at risk: Number at risk.
- Citation: Meijer LL, Strijker M, de Bakker JK, Toennaer JG, Zonderhuis BM, van der Vliet HJ, Wilmink H, Verheij J, Daams F, Busch OR, van Grieken NC, Besselink MG, Kazemier G. Clinical outcomes of patients with duodenal adenocarcinoma and intestinal-type papilla of Vater adenocarcinoma. World J Gastrointest Oncol 2020; 12(3): 347-357
- URL: https://www.wjgnet.com/1948-5204/full/v12/i3/347.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v12.i3.347